Costakis Frangou

Roswell Park Comprehensive Cancer Center

Also affiliated with University of Toledo

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Pharmacologically targeting KRAS G12D in PDAC models: tumor cell intrinsic and extrinsic impact”.

Pharmacologically targeting KRAS G12D in PDAC models: tumor cell intrinsic and extrinsic impact

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.18.533261

N/A

0DataRank · unranked

3 citations

Costakis Frangou, Jianxin Wang, Yin Wan, Andrew Dynka, Hanna R. Rosenheck +5 more

The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer

Cancer Research(2024)10.1158/0008-5472.can-23-2504

N/A

0DataRank · unranked

48 citations

Jianxin Wang, Costakis Frangou, Yin Wan, Andrew Dynka, Hanna R. Rosenheck +5 more

Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle

Nature Communications(2025)10.1038/s41467-025-56674-4

N/A

0DataRank · unranked

35 citations

Jianxin Wang, Michelle Roti, Yin Wan, Adam P. Dommer, Hanna R. Rosenheck +11 more